Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI)

NCT04120610 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT04120610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI)
Lead sponsor
Medtronic Endovascular
Phase
Observational
Overall status
Terminated
Start date
December 9, 2019
Completion date
November 21, 2022
Enrollment
195 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease